Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Share Capital

v3.20.2
Note 9 - Share Capital
 6 Months Ended
Jun. 30, 2020
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
9.
 Share capital:
 
The Company has authorized share capital of an unlimited number of common voting shares.
 
(a)
 Equity issuances:
 
(i)
June 2019
Confidentially Marketed Public Offering (CMPO)
 
On
June 3, 2019,
the Company completed a confidentially marketed public offering through the issuance of
11,500,000
common shares at a price of
$1.85
per share for gross proceeds of
$21.275
million (approximately
$19.594
million net of share issue costs). Costs associated with the proceeds consisted of a
7%
cash commissions and share issue costs, which consisted of agent commission, legal and professional fees and listing fees.
 
(ii)
2019
Share Purchase agreement
 
On
May 7, 2019,
the Company entered into the
2019
Aspire Purchase Agreement, which provided that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital is committed to purchase up to an aggregate of
$20
million of Common Shares over approximately
30
months. Pursuant to the terms of this agreement, on
May 13, 2019,
the Company issued
171,428
Common Shares (“Commitment Shares”) to Aspire Capital in consideration for entering into the
2019
Aspire Purchase Agreement for a total cost of
$360
thousand. The Aspire share purchase agreement was terminated on
December 16, 2019.
As at
June 30, 2019,
the Company had
not
issued any shares under the
2019
Aspire Purchase Agreement, other than the Commitment Shares.
 
(iii)
2018
Share Purchase agreement
 
On
May 30, 2018,
the Company entered into the
2018
Aspire Purchase Agreement, which provides that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital is committed to purchase up to an aggregate of
$20
million of Common Shares over approximately
30
months. Pursuant to the terms of this agreement, on
June 8, 2018,
the Company issued
170,261
Common Shares (“Commitment Shares”) to Aspire Capital in consideration for entering into the
2018
Aspire Purchase Agreement for a total cost of
$600
thousand. During the period from
January 1, 2019
up to
May 24, 2019,
the date the
2018
Aspire Purchase Agreement was terminated, the Company issued
5,502,433
common shares under the agreement at an average price of
$1.82
per share for gross and net proceeds of
$10
million. On a cumulative basis up to
May 24, 2019,
the Company raised a total of approximately
$11.9
million gross and net proceeds under the
2018
Aspire Purchase Agreement. As of
May 24, 2019,
the Company has issued
6,409,980,
the maximum number of shares issuable under this facility without shareholder approval.
 
(iv)
2018
At-The-Market (“ATM”) Facility
 
On
March 27, 2018,
the Company entered into an “At-The-Market” Facility (“ATM”) equity distribution agreement with Cantor Fitzgerald acting as sole agent. Under the terms of this facility, the Company
may,
from time to time, sell shares of our common stock having an aggregate offering value of up to
$30
million through Cantor Fitzgerald on the Nasdaq Capital Market. During the
six
months ended
June 30, 2019,
the Company issued
77,349
shares under this ATM equity facility at an average price of
$2.37
for gross proceeds of
$183
thousand (
$178
thousand net of share issue costs). Costs associated with the proceeds consisted of a
3%
cash commission. On a cumulative basis to
June 30, 2019,
the Company has raised a total of
$11.2
million gross proceeds (
$10.9
million net of share issue costs) under the ATM Facility. The Company terminated this agreement on
May 24, 2019.
 
(b)
 Loss per share:
 
Loss per common share is calculated using the weighted average number of common shares outstanding and is presented in the table below:
 
    Three months ended
June 30,		   Six months ended
June 30,
(in thousands)     2020       2019       2020       2019  
                                 
Net loss   $
(15,750
 )   $
(6,218
 )   $
(27,276
 )   $
(11,724
 )
Weighted-average common shares – basic and diluted    
76,275
      
46,474
      
76,251
      
43,178
  
Net loss per share – basic and diluted   $
(0.21
 )   $
(0.13
 )   $
(0.36
 )   $
(0.27
 )
 
The effect of any potential exercise of the Company's stock options outstanding during the
three
and
six
month periods ended
June 30, 2020
and
June 30, 2019
has been excluded from the calculation of diluted loss per common share as it would be anti-dilutive.